Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects

NCT01349114 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Sponsor requested termination.

Conditions

Diabetes
Pre-hypertension
Hypertension

Interventions

DRUG: aliskiren 300 mg once daily
DRUG: Placebo/sugar pill

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]